Distinct states of nucleolar stress induced by anticancer drugs
eLife · 15.12.2023 · 12
DOI: 10.7554/elife.88799 ↗Kurz gefasst
Fachartikel in der Zeitschrift eLife, online erschienen am 15.12.2023. Verfasst von Tamara A Potapova und 6 weiteren Autor:innen. Beteiligte Einrichtung: Stowers Institute for Medical Research, Kansas City, United States. Hauptthemen laut MEDLINE: Cell Nucleolus, Antineoplastic Agents. Die Arbeit wurde bisher 69-mal zitiert (Crossref) und nennt 74 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIGMS NIH HHS, National Institute of General Medical Sciences.
Abstract (Originalsprache)
Ribosome biogenesis is a vital and highly energy-consuming cellular function occurring primarily in the nucleolus. Cancer cells have an elevated demand for ribosomes to sustain continuous proliferation. This study evaluated the impact of existing anticancer drugs on the nucleolus by screening a library of anticancer compounds for drugs that induce nucleolar stress. For a readout, a novel parameter termed ‘nucleolar normality score’ was developed that measures the ratio of the fibrillar center and granular component proteins in the nucleolus and nucleoplasm. Multiple classes of drugs were found to induce nucleolar stress, including DNA intercalators, inhibitors of mTOR/PI3K, heat shock proteins, proteasome, and cyclin-dependent kinases (CDKs). Each class of drugs induced morphologically and molecularly distinct states of nucleolar stress accompanied by changes in nucleolar biophysical properties. In-depth characterization focused on the nucleolar stress induced by inhibition of transcriptional CDKs, particularly CDK9, the main CDK that regulates RNA Pol II. Multiple CDK substrates were identified in the nucleolus, including RNA Pol I– recruiting protein Treacle, which was phosphorylated by CDK9 in vitro. These results revealed a concerted regulation of RNA Pol I and Pol II by transcriptional CDKs. Our findings exposed many classes of chemotherapy compounds that are capable of inducing nucleolar stress, and we recommend considering this in anticancer drug development.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Stowers Institute for Medical Research, Kansas City, United States.
- Department of Biochemistry and Molecular Genetics, University of Alabama at Birmingham, Birmingham, United States.
- Department of Biochemistry and Molecular Biology, University of Kansas Medical Center, Kansas City, United States.
ORCID-Profile: Tamara A Potapova, Jay R Unruh, Laurence Florens, David Alan Schneider, Jennifer L Gerton
Förderung
- NIGMS NIH HHS
- National Institute of General Medical Sciences
Zitieren
APA
Potapova, T. A., Unruh, J. R., Conkright-Fincham, J., Banks, C. A. S., Florens, L., Schneider, D. A., & Gerton, J. L. (2023). Distinct states of nucleolar stress induced by anticancer drugs. eLife, 12. https://doi.org/10.7554/elife.88799
Vancouver
Potapova TA, Unruh JR, Conkright-Fincham J, Banks CAS, Florens L, Schneider DA, et al. Distinct states of nucleolar stress induced by anticancer drugs. eLife. 2023;12. doi:10.7554/elife.88799
BibTeX
@article{Potapova2023,
author = {Potapova, Tamara A and Unruh, Jay R and Conkright-Fincham, Juliana and Banks, Charles A S and Florens, Laurence and Schneider, David Alan and Gerton, Jennifer L},
title = {Distinct states of nucleolar stress induced by anticancer drugs},
journal = {eLife},
year = {2023},
volume = {12},
doi = {10.7554/elife.88799}
}
EUVIMED